Related Experiment Video
Updated: Jan 14, 2026

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Clinical outcome measures
Alexandria Matic1, Yvonne Campman2, Martijn Rudolf Tannemaat2
1Division of Neurology, Department of Medicine, Prosserman Family Neuromuscular Clinic, University of Toronto, Toronto, ON, Canada.
Abstract:
The typical fluctuating skeletal muscle weakness in myasthenia gravis can make measuring disease severity challenging. Multiple measures have been developed to assess the signs and symptoms of myasthenia, from pure examination measures to fully patient-reported measures to combinations. There are also measures aimed at assessing quality of life and satisfaction. Electrophysiology and serology have also been used in some studies as surrogate outcomes. In this chapter, we review outcomes specifically developed to assess disease severity in myasthenia, as well as quality of life, and data on electrophysiology and serology as outcome measures.
Related Concept Videos
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Nursing Evaluation
Kaplan-Meier Approach
Cancer Survival Analysis
Clinical Trials
There are four phases in a clinical trial. A phase one...

